Sterling pilot plant facility expansion up and running4 Jun 2019
Additional three new reactor trains will help the CDMO to meet growing market demand for smaller API batch sizes.
CDMO Sterling Pharma Solutions has announced the expansion of its pilot plant facility is now operational at its UK site following a £6-million investment last year.
The new cGMP facility increases the existing pilot plant’s capacity by 33%, enhancing the CDMO’s scale-up capabilities and adding greater flexibility to cater for small to mid-scale clinical supply and commercial batch production.
The investment included the addition of three new reactor trains at scales of 225 L, 500 L and 1,360 L, which will help the company to meet growing market demand for smaller API batch sizes.
Kevin Cook, CEO at Sterling Pharma Solutions says: “We’ve experienced significant growth over the past few years and as demand rises, we have taken steps to bolster our offering.
“There are a number of increasingly complex products entering the drug pipeline, many of which are intended for smaller patient populations, so the ability to cater for smaller volumes will be essential as we move forward.
“In addition, increasingly our customers are coming to us for an end-to-end API development and manufacturing offering that will allow them to outsource the entire process. The expansion of our pilot plant will increase our scale-up abilities and allow us to cater for additional projects from proof-of-concept through to commercial manufacture.”
The investment will also allow Sterling Pharma Solutions to handle potent compounds across a range of equipment scales, complementing the company’s existing offering.
New HCP Kit for automated impurity analysis of biotherapeutics
21 Jun 2019
Ready-to-use immunoassay kit increases analytical output and productivity in bioprocess workflows.Read more
Sanofi and Google to develop new healthcare Innovation Lab
20 Jun 2019
Collaboration aims to change how Sanofi develops new treatments and will focus on to better understand patients and diseases, to increase Sanofi’s operational efficiency, and to improve the experience of Sanofi’s patients and customers.Read more
Catalent to purchase BMS manufacturing facility
19 Jun 2019
Customers to have access to state-of-the-art sterile biologics fill/finish and oral solids manufacturing and packaging platforms.Read more
Inaugural Bio Integrates conference highlights industry's inefficiency in developing products
18 Jun 2019
Industry leaders give voice to issues and trends shaping the biotech sector, including the importance of collaboration.Read more
Colorcon launches Opadry Enteric for use with hydro-alcoholic media
17 Jun 2019
A fully formulated one-step system providing simple preparation and ease-of-use for film coating.Read more
SenzaGen granted its first patent for GARD potency biomarker test
16 Jun 2019
Company can now offer an animal-free test method to quantify the strength of an allergenic effect.Read more
Affordable measles and rubella vaccines using NevoLine manufacturing platform
14 Jun 2019
Univercells' propriety bioproduction platform has already proven success.Read more
Leaf Expression Systems launches first line of Hypertrans research products
13 Jun 2019
Plant-expression deal for difficult to produce proteins, vaccines, metabolites and natural proteins.Read more
Clinical supply milestone reached for triple-negative breast cancer treatment
12 Jun 2019
PhoenixMD and WuXi STA have produced a multikilogram drug supply for PMD-026 under GMP manufacturing practices.Read more
Combining IT and OT software to solve manufacturing’s most frequent challenges
11 Jun 2019
PTC and Rockwell Automation combine technologies to accelerate customers’ digital transformation initiatives.Read more
Are you a supplier
Here's what we can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation